Načítá se...
Recent developments in receptor tyrosine kinases targeted anticancer therapy
Novel concepts and understanding of receptors lead to discoveries and optimization of many small molecules and antibodies as anti-cancerous drugs. Receptor tyrosine kinases (RTKs) are such a promising class of receptors under the investigation in past three decades. RTKs are one of the essential med...
Uloženo v:
| Vydáno v: | Vet World |
|---|---|
| Hlavní autoři: | , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Veterinary World
2016
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4819356/ https://ncbi.nlm.nih.gov/pubmed/27051190 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.14202/vetworld.2016.80-90 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|